iiinova — where your digital self keeps evolving

JAMA Health Forum @jamahealthforum.com · 20/10/2026

How should #policymakers address rising #HealthCare costs? JAMA Health Forum is soliciting Viewpoints on #policy strategies to improve #affordability and address #spending. Authors may submit policy-focused perspectives through December 31, 2026. ja.ma/3VUfzit

JAMA Health Forum banner reading "Inviting Viewpoints on Strategies to Address Health Care Costs" with editors Melinda Buntin, Pragya Kakani, and Sandro Galea listed.

000 0

JAMA Health Forum @jamahealthforum.com · 09/10/2026

📈 #PharmacyBenefitManagers and opioid manufacturers had undisclosed financial relationships that encouraged increased dispensing of branded opioids in this study of litigation documents from 1997 to 2018. ja.ma/3Vz9cAZ

Flowchart shows pharmaceutical financial flow. Pharmacy pays drug manufacturers (Purdue, Endo, etc.) and interacts with Pharmacy benefit managers (PBMs) like Optum Rx, Caremark. PBMs get discount fees from pharmacies & rebates from manufacturers. PBMs reimburse pharmacies, pass rebates to health insurance.

010 1

JAMA Health Forum @jamahealthforum.com · 25/09/2026

In Pennsylvania, nonprofit #AmbulatorySurgeryCenters had higher profit margins than for-profit centers and accounted for a larger share of total net income relative to their share of facilities. ja.ma/4cYTqW2

022 2

JAMA Health Forum @jamahealthforum.com · 25/09/2026

In Medicaid, covering obesity-labeled #GLP1 receptor agonists was associated with higher obesity-labeled use, while total glucagon-like peptide-1 receptor agonist use increased less, suggesting possible substitution across label indications. ja.ma/4xPkKxn

021 2

JAMA Health Forum @jamahealthforum.com · 19/09/2026

📊 Among Medicare beneficiaries who reached the Inflation Reduction Act Part D cap in 2025, most without a low-income subsidy paid less than the full $2000 out of pocket, with lower payments in Medicare Advantage plans vs stand-alone Part D plans ja.ma/4jby4s5

Bar graphs show mean beneficiary-paid amount towards a $2000 cap by quarter & Part D enrollment in 2025. PDP (non-LIS) (pink) is highest (~$1200-1500), MAPD (non-LIS) (green) lower (~$800-1200), LIS (blue) is minimal. Data for Overall & Quarters 1-4. Y-axis: payment ($).

000 0

JAMA Health Forum @jamahealthforum.com · 19/09/2026

📝 Viewpoint: #SchoolBasedHealthServices support student health and educational achievement, but projected federal Medicaid reductions under the One Big Beautiful Bill Act may disrupt access to these services, particularly in low-income and rural districts ja.ma/4yPdN0h

Document titled 'Viewpoint: Federal Funding Cuts and the Future of Health Care in Schools' by Angélica Meinhofer, Caroline H. Kelly, Sasha Pudelski, and Jessie Mandle. It discusses school-based health services funding & the impact of a new bill on Medicaid.

000 0

JAMA Health Forum @jamahealthforum.com · 18/09/2026

For adults with #schizophrenia, #CommunityBasedRehabilitation was associated with improved outcomes and cost savings across health system, multipayer, and societal perspectives in a resource-constrained setting. ja.ma/4ivP38k

Table 3, titled 'Cost-Effectiveness Results of Community-Based Rehabilitation Among People With Schizophrenia in China', presents financial and effectiveness data for QALYs, PANSS, PSP, and BAS scores from health system, multipayer, and societal perspectives.

010 1

JAMA Health Forum @jamahealthforum.com · 07/09/2026

In Virginia, preventive care reimbursement in #Medicaid managed care exceeded Medicaid fee-for-service, but remained below rates paid by employer-sponsored insurance, Marketplace plans, and #MedicareAdvantage. ja.ma/4rhwU0x

Figure 1. Four box plots show 2023 physician preventive care rates in Virginia. Rates vary by CPT code (99385, 99386, 99395, 99396) and insurance plan (ESI, Marketplace, MA, Medicaid MCO). A dashed line indicates $100.

000 0

JAMA Health Forum @jamahealthforum.com · 07/09/2026

In privately insured patients, rising #HealthInsurance premiums were largely associated with growth in health spending rather than growth in insurer markups. Efforts to slow premium growth may need to focus on reducing underlying health care spending. ja.ma/4yJiskr

Two graphs, 2011-2024. Left: Line graph shows mean insurance premiums ($) (orange) consistently higher & increasing faster than mean health spending ($) (blue). Right: Bar graph shows insurer markup (%) fluctuating, with highs around 2018-2020.

000 0

JAMA Health Forum @jamahealthforum.com · 06/09/2026

Among commercially insured adults with #Obesity initiating semaglutide, higher out-of-pocket costs were associated with lower adherence, indicating that financial barriers may limit sustained use and reduce access to the benefits of treatment. ja.ma/4yis8Sw

Two line graphs showing adjusted differences in (A) predicted nonadherence and (B) proportion of days covered for Semaglutide by out-of-pocket cost quintile (Q1-Q5). Nonadherence probability (vs Q1) rises to ~0.09 by Q5. Days covered probability drops to ~-0.08 by Q5.

033 3

JAMA Health Forum @jamahealthforum.com · 06/09/2026

#Medicaid work-reporting requirements may place working adults at risk of coverage loss even when they are employed, because near-threshold or inconsistent work hours can lead to noncompliance. ja.ma/4cwp3G8

US map showing states categorized by the proportion of adults (18-64) at risk of Medicaid noncompliance subject to work requirements. Legend: >20% (darkest), 15-20%, <15% (lightest), and Excluded (gray). Many southern/midwestern states are excluded.

000 0

JAMA Health Forum @jamahealthforum.com · 06/09/2026

Natural language processing of #Medicaid care coordination notes identified paperwork, scheduling, transportation, and #PriorAuthorization delays as major administrative burdens and offers a scalable way to monitor burden by type. ja.ma/4gPBA8P

Circle plot: Administrative burden prevalence (%) vs. time cost per patient ($). Circle size = affected patients. Transportation (12k patients) highest cost ~$47, low prevalence (~7%). Paperwork (6k patients) highest prevalence (~25%), moderate cost (~$23). Scheduling (6k patients) lowest cost ~$11. Prior auth (2k patients) moderate cost ~$18, low prevalence.

020 2

JAMA Health Forum @jamahealthforum.com · 06/09/2026

📝 Viewpoint: Prescription-to-#OverTheCounter switching may improve convenience and some forms of access, but without reimbursement for pharmacist-led care and patient education, it may shift cost and risk to patients. ja.ma/4xbh20C

Webpage showing a JAMA Health Forum article titled "Prescription to Over-the-Counter Switching as a Policy Tool." Authors are T. Joseph Mattingly II and Rena M. Conti. Published online August 28, 2026.

000 0

JAMA Health Forum @jamahealthforum.com · 06/09/2026

The 2016 Brexit referendum was associated with increased #NHS physician vacancies, indicating that higher non-EU recruitment did not fully offset workforce shortages. ja.ma/4qZyrb9

Three line graphs chart nurse inflow to the UK (EU, Non-EU, Total), showing 'nurses who emigrated' 2008-2019. Post-2016 Brexit referendum, observed EU inflow sharply dropped. Non-EU inflow dipped then rose sharply. Total inflow fell, partially recovering below predicted trends.

031 3

JAMA Health Forum @jamahealthforum.com · 06/09/2026

Among #MedicareAdvantage beneficiaries, new complex medical conditions were associated with higher disenrollment, especially to #TraditionalMedicare, and the increase grew with the number of conditions. ja.ma/4r5KwvG

Three line graphs show enrollment (2017-2021) for TM/MA plans by number of new conditions. Post-2019, Enrollment in TM (B) rises sharply for patients with new conditions, especially ≥4 (reaching >25%). Enrollment in different MA plans (C) slightly decreases for all categories.

020 2

JAMA Health Forum @jamahealthforum.com · 28/08/2026

⏰ Last call! Applications for the JAMA Health Forum Editorial Fellowship program are due Tuesday, September 1. 🔗 Find the requirements and application details here: ja.ma/4fR5jh8

011 1

JAMA Health Forum @jamahealthforum.com · 24/08/2026

JAMA Health Forum is offering three editorial fellowship positions in different areas of focus for doctoral scholars interested in working with a health policy and health services journal. 📅 Deadline: Sept 1, 2026 🔗 ja.ma/45B8k0m

001 1

JAMA Health Forum @jamahealthforum.com · 22/08/2026

JAMA Health Forum™ and JN logos. Text: "Call for Applications: Editorial Fellowship Due September 1, 2026." A person's hands type on a laptop keyboard, shown with a blue overlay.

001 1

JAMA Health Forum @jamahealthforum.com · 21/08/2026

💬 Viewpoint by Dhruv Khullar, MD, MPP, Sachin Jain, MD, MBA, and Amelia Bond, PhD: Voluntary multiyear enrollment in #MedicareAdvantage could reduce annual churn and better support preventive care, chronic disease management, and care continuity. ja.ma/4c449Oj

Webpage displaying a JAMA Health Forum 'Viewpoint' article: 'Toward Multiyear Enrollment in Medicare Advantage.' Authored by Dhruv Khullar, Sachin H. Jain, and Amelia M. Bond. Published Online: August 21, 2026. The page includes navigation and interaction icons.

000 0

JAMA Health Forum @jamahealthforum.com · 21/08/2026

New complex medical conditions were associated with higher #MedicareAdvantage disenrollment, especially to traditional Medicare, and disenrollment increased with the number of new conditions. ja.ma/4gL5s7u

Three line graphs show enrollment percentages (2017-2021). A vertical line marks 2019. Legend: No to ≥4 new complex conditions. Graph A: Enrollment in TM or different MA plan. Graph B: Enrollment in TM. Graph C: Enrollment in different MA plan. Post-2019, TM enrollment (B) rises sharply for those with more new conditions, while other MA plan enrollment (C) declines for all conditions.

000 0

JAMA Health Forum @jamahealthforum.com · 21/08/2026

After the Brexit referendum, European Union #Physicians and #Nurses immigrating to the UK declined, while non–European Union recruitment increased and National Health Service physician vacancies rose. ja.ma/45GQd9n

Three graphs display UK nurse inflow 2008-2019. After the 2016 Brexit referendum: EU nurse inflow sharply dropped from predicted levels. Non-EU inflow dipped then increased. Total nurse inflow dipped then recovered. Control countries' inflow remained low.

021 2

JAMA Health Forum @jamahealthforum.com · 18/08/2026

JAMA Health Forum is seeking editorial fellows for a 1-year, hands-on fellowship program beginning January 1, 2027. Fellows will receive training in the editorial processes and policies of a major health policy and health services journal. 📅 Apply by Sept 1: ja.ma/4fina04

010 1

JAMA Health Forum @jamahealthforum.com · 15/08/2026

💬 Editorial by JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, and Nason Maani, PhD: Research on commercial determinants of health can help clarify how corporate practices and policy environments shape #HealthEquity and population health. ja.ma/4hwkMG1

JAMA Health Forum article page displaying an Editorial titled 'Centering Corporate Activity in the Population Health Research Agenda' by Sandro Galea and Nason Maani. Published Online: August 14, 2026, with publication details and DOI.

000 0

JAMA Health Forum @jamahealthforum.com · 15/08/2026

Patients classified as likely undocumented had higher in-person outpatient visit completion overall, but month-specific declines in 2025 and increased #Telehealth use indicate shifts in access during intensified federal immigration enforcement. ja.ma/4zksxFo

Line graph: Change in outpatient visit completion rate (%), 2024-2025, over 6 months. 'NEPL without SSN' (orange) starts high at 4.3%, drops to -3% (month 3), then rises and falls. 'EPL with SSN' (teal) starts at 1.5%, drops to -1.8% (month 2), then steadily rises.

001 1

JAMA Health Forum @jamahealthforum.com · 15/08/2026

As #DualEligibleSpecialNeedsPlans expanded, higher maximum out-of-pocket limits after the 2023 policy change may shift payment responsibility from state #Medicaid programs to #MedicareAdvantage organizations earlier in the spending trajectory. ja.ma/4bSxPxT

Line graph showing Mean MOOP limit ($) from 2017-2026. A "MOOP recalculation" in 2023 causes all lines to increase sharply. Combined (D-SNPs) and Combined (non-SNPs) lines are highest. In network (D-SNPs) and In network (non-SNPs) lines are lower.

000 0

JAMA Health Forum @jamahealthforum.com · 15/08/2026

State #EvictionMoratoria were associated with fewer foster care entries related to inadequate housing, caregiver inability to cope, and physical abuse, but not with a significant difference in total foster care entries. ja.ma/4x0nZ5r

Four line graphs display adjusted foster care entry rate indices for 'Always treated' (dark grey) and 'Never treated' (orange) groups, from Jan 2019 to Aug 2021. A vertical line marks 'EM implementation' in Mar 2020. All graphs show rates declining for total, physical abuse, caregiver inability, and inadequate housing after EM implementation.

000 0

JAMA Health Forum @jamahealthforum.com · 15/08/2026

For high-cost #PrescriptionDrugs, a #RealTimePrescriptionBenefit tool was associated with higher fill rates, suggesting a targeted approach may better reduce cost-related nonadherence than universal deployment. ja.ma/3SdUzl7

JAMA Health Forum study: RCT on Real-Time Prescription Benefit Tool (RTPB) & Prescription Fill Rates. Of 38,289 orders, RTPB (23,226 orders) offered lower-cost alternatives vs. control (15,063 orders). Bar chart shows RTPB increased high-cost drug fill rates from 33% to 49%, and overall from 54% to 55%. Study in 1 US ambulatory network.

010 1

JAMA Health Forum @jamahealthforum.com · 13/08/2026

📢 Now accepting applications: 2027 JAMA Health Forum editorial Fellowship. Scholars with a doctoral degree interested in the policies that shape health are encouraged to apply for this fellowship to receive hands on training. Applications due September 1, 2026. 🔗 ja.ma/4fina04

000 0

JAMA Health Forum @jamahealthforum.com · 10/08/2026

Biologics and therapeutics from larger companies reached #MostFavoredNation markets sooner than small-molecule drugs and products from smaller companies, which may affect Medicare pricing benchmarks under GLOBE and GUARD. ja.ma/4fIIVrA

Table 1: Characteristics & MFN Market Launches of FDA-Approved Therapeutics for GLOBE/GUARD Models. Summarizes 79 drugs by type, area, origin, & approval status. Shows median months to 1st MFN launch (6.3) & % launched in ≥1 MFN country by 5 years (91.1%).

000 0

JAMA Health Forum @jamahealthforum.com · 09/08/2026

📣 Special Communication: For #Medicaid work requirements under the Budget Reconciliation Act of 2025, #ArtificialIntelligence could help states screen eligibility, review documentation, and identify people at risk of procedural disenrollment. ja.ma/45eyS7C

Table: AI Augmentation of Health Care Policy Implementation. It details five domains: Process execution, Targeting, Communication, Monitoring, and Adaptation. For each domain, it lists Medicaid work requirement implementation needs and provides AI-augmented policy examples. Abbreviations: AI, LLM.

000 0

JAMA Health Forum @jamahealthforum.com · 09/08/2026

After New York State expanded #Medicaid and #MedicareSavingsProgram eligibility in 2023, dual enrollment among Medicare beneficiaries rose above projected levels, indicating broader access to financial assistance. ja.ma/4q4OdkI

Two graphs show enrollment trends (Jan 2021-Nov 2023). Graph A: Enrollment percentage for Medicaid (without MSP) sharply drops in early 2023, while Medicaid and MSP percentage rises. Graph B: Number of enrollees for Medicaid (without MSP) decreases significantly as Medicaid and MSP increases, while MSP (without Medicaid) remains stable in both.

010 1

JAMA Health Forum @jamahealthforum.com · 09/08/2026

In US #NursingHome markets, ownership transitions and bed-capacity changes became more common over time than permanent closure, indicating that organizational restructuring is a central market dynamic. ja.ma/4xtqnBz

Stacked bar chart showing the number of events by type from 1985 to 2025. Total events (Termination, Entry, Capacity change, CHOW) decrease sharply from ~7500 in 1985 (mainly Termination) to under 1000 by 2025, where Capacity change is highest.

010 1

JAMA Health Forum @jamahealthforum.com · 09/08/2026

000 0

JAMA Health Forum @jamahealthforum.com · 08/08/2026

Among high-risk therapeutic #MedicalDevices approved through the US Food and Drug Administration premarket approval pathway, more than 1-third were later subject to serious recalls, supporting stronger postmarket surveillance. ja.ma/4z5Nh3u

Two graphs. A) Serious (Class I or II) recalls: Percentage of devices with recalls rises from 0% to ~45% over 11 years. No. at risk starts at 193. B) Class I recalls: Percentage of devices with Class I recalls rises from 0% to ~15% over 11 years. Both have shaded confidence intervals.

002 2

JAMA Health Forum @jamahealthforum.com · 08/08/2026

Mandatory #ValueBasedCare programs by the Centers for Medicare & Medicaid Services were associated with higher hospital administrative costs, adding more than $3 billion in annual costs nationally. ja.ma/4z1C1oZ

Three line graphs show annual administrative costs per hospital (Maryland acute, critical access, long-term acute) from 2008-2017. All show costs near zero until 2012, then rising significantly over time, with increasing confidence intervals. Cost estimate and 95% CI are indicated.

000 0

JAMA Health Forum @jamahealthforum.com · 08/08/2026

Expanding #Alcohol screening and brief intervention in primary care was projected to reduce premature mortality by 2030, especially when brief intervention delivery increased substantially. ja.ma/4fXJoFg

000 0

JAMA Health Forum @jamahealthforum.com · 05/08/2026

JAMA Health Forum announces a 'Call for Applications: Editorial Fellowship.' Deadline: 'Due September 1, 2026.' Background shows hands typing on a laptop keyboard.

020 2

JAMA Health Forum @jamahealthforum.com · 04/08/2026

Across the US, France, Germany, and Switzerland, median total time from clinical trial initiation to reimbursement for new #Drugs changed little from 2014 to 2024. ja.ma/4bLjFP9

Stacked bar chart of drug approval timelines across US, France, Germany, Switzerland. It shows years for Clinical Development, Regulatory Review, & Reimbursement Review for All, Standard, & Expedited processes, highlighting varying durations per stage & process type.

000 0

JAMA Health Forum @jamahealthforum.com · 04/08/2026

Venture-backed #MaternalHealth startups raised nearly $1 billion from 2014 to 2022, with investment concentrated in diagnostics and virtual or hybrid wraparound pregnancy care. ja.ma/3Tq3hNF

Line graph: Investment value ($ in millions) for 8 healthcare categories, 2014-2022. Most categories, esp. Virtual/hybrid pregnancy care, Maternal/fetal diagnostics, & Maternal/fetal treatment, show significant growth from 2020-2022. Virtual/hybrid pregnancy care peaked over $50M in 2022.

010 1

JAMA Health Forum @jamahealthforum.com · 03/08/2026

Biologics and products from larger companies reached #MostFavoredNation markets sooner after US launch than small-molecule drugs and products from smaller companies. ja.ma/4pTZYdG

A JAMA Health Forum research letter titled 'Novel Drug Launches in Most-Favored-Nation Countries and Medicare Pricing Benchmarks' by Mengyuan Fu, Rohini Ghosh, Erfan Taherifard, et al., published online July 31, 2026.

000 0

JAMA Health Forum @jamahealthforum.com · 03/08/2026

In US #NursingHomes, change of ownership and bed capacity reconfiguration became more common over time and were more prevalent than permanent closure or market exit. ja.ma/4yYBGU4

Stacked bar chart of No. of terminations by type across 5-year periods from 1990 to 2025. Total terminations decrease from ~4300 in 1990 to ~900 in 2020. "Ownership/organizational transition" is the largest reason, followed by "Voluntary/other reason."

001 1

JAMA Health Forum @jamahealthforum.com · 03/08/2026

Expanding #Alcohol brief intervention in primary care was projected to reduce premature mortality by 2030, while screening expansion alone had little measurable effect on potential years of life lost. ja.ma/3TASaBt

Three line graphs display adults with hazardous alcohol use receiving brief intervention by education level (2025-2030). They show percentages increase over time, especially for universal ASBI (Scenario 4) and +8M interventions (Scenario 3). Women consistently have higher intervention rates than men across all education groups.

001 1

JAMA Health Forum @jamahealthforum.com · 31/07/2026

📢 Now accepting applications: 2027 JAMA Health Forum Editorial Fellowship. Scholars with a doctoral degree interested in the policies that shape health are encouraged to apply for this fellowship. Apply by Sept. 1, 2026. 🔗 ja.ma/45fkJH6

000 0

JAMA Health Forum @jamahealthforum.com · 29/07/2026

Flavored #tobacco bans did not impact cigarette smoking rates among high school students, suggesting targeted bans may reduce #vaping. 📖 Read the full article for more details: ja.ma/4pJL5e0

100 1

JAMA Health Forum @jamahealthforum.com · 27/07/2026

012 2

JAMA Health Forum @jamahealthforum.com · 23/07/2026

000 0

JAMA Health Forum @jamahealthforum.com · 18/07/2026

JAMA Health Forum is seeking editorial fellows for a 1-year, hands-on fellowship program beginning January 1, 2027. Fellows will receive training in the editorial processes & policies of a major health policy & health services journal. 📅 Apply by Sept 1: ja.ma/3T2jAzT

010 1

JAMA Health Forum @jamahealthforum.com · 15/07/2026

📢 Now accepting applications: 2027 JAMA Health Forum editorial Fellowship. Scholars with a doctoral degree interested in the policies that shape health are encouraged to apply. Applications due September 1, 2026. 🔗 ja.ma/44ZrCfA

000 0

JAMA Health Forum @jamahealthforum.com · 11/07/2026

Following open notes implementation, 55% of patients viewed #ambulatory visit notes, but engagement was lower among men, non-English speakers, and those in low-income or low-internet-access areas. ja.ma/4bi9nWc

Two graphs: A) Patients viewing open notes rose from near 0% to ~53% from late 2020 to early 2021, then stabilized. B) The distribution of time to engagement shows most patients view notes very quickly, peaking at 0-1 hour then sharply declining over time.

000 0

JAMA Health Forum @jamahealthforum.com · 11/07/2026

The share of MA beneficiaries in plans with $0 cost sharing for in-network #PCP visits rose from 46% in 2019 to 78% in 2025, but availability is lower in zero-premium and high-poverty counties. #MedicareAdvantage ja.ma/4bCfODD

Dual-axis graph shows trends from 2019-2025. MA enrollees (line, left axis) grow from ~47% to ~78%. Total enrollment (bars, right axis) increases from ~7 million to ~22 million. Both metrics show a clear upward trend across the years.

010 1